Is this your brand? Sign in to claim ownership.
Sign in to claim this brandKING SYSTEMS CORPORATION.
US
Last updated September 17, 2026
Information
- Country
- US
- Address
- 15011 HERRIMAN BLVD., Noblesville, IN, 46060
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- 1824226
- DUNS Number
- —
Catalogue (1113)
Page 1 of 23| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Adult Ultra Flex®anesthesia Breathing Circuit | 5753F-14621Z | FDA UDI | Class I | Active |
| Adult Ultra Flex®anesthesia Breathing Circuit | 81213F-13621Z | FDA UDI | Class I | Active |
| Jackson Rees | 3841Z | FDA UDI | Class I | Active |
| Pediatric Ultra Flex®anesthesia Breathing Circuit | GH21212P-6121 | FDA UDI | Class I | Active |
| Ventilator Circuit | 20760F-A | FDA UDI | Class I | Unknown |
| Universal F® Flex2® | AF370-6121Z | FDA UDI | Class I | Active |
| Custom Kit | D066 | FDA UDI | Class I | Active |
| Adult Ultra Flex®anesthesia Breathing Circuit | 6754F-61Z | FDA UDI | Class I | Unknown |
| Breathing Bag | 20905-10 | FDA UDI | Class I | Active |
| Breathing Bag | 5107 | FDA UDI | Class I | Active |
| Adult Ultra Flex® | 81813B-61Z | FDA UDI | Class I | Active |
| Adult Ultra Flex®anesthesia Breathing Circuit | AJ6903F-16421Z | FDA UDI | Class I | Active |
| Custom Accessory | D077 | FDA UDI | Class I | Active |
| Pediatric Ultra Flex®anesthesia Breathing Circuit | 2707Y-13621 | FDA UDI | Class I | Active |
| Universal Flex2® | KNCF3116-6121Z | FDA UDI | Class I | Active |
| Ped F2® Pediatricanesthesia Breathing Circuit | PD140-61Z | FDA UDI | Class I | Active |
| KING LTS-D Kit | KLTSD435 | FDA UDI | Class I | Active |
| Adult Anesthesia | 8600B-84 | FDA UDI | Class I | Active |
| Disposable Xenon Circuitfor Nuclear Medicine | 21129 | FDA UDI | Class II | Active |
| Universal Flex2®breathing Circuit & Pack Kit | F90757 | FDA UDI | Class I | Unknown |
| Ventilator Circuit | 40611-2 | FDA UDI | Class I | Active |
| Infant Size 2 | 1925 | FDA UDI | Class I | Active |
| Disposable Xenon Circuitfor Nuclear Medicine | 22526 | FDA UDI | Class II | Active |
| Ulti-Mist | MS-131 | FDA UDI | Class I | Active |
| Mapleson C Circuit | 4231Z | FDA UDI | Class I | Active |
| Universal Flex2®breathing Circuit | DF477S-6121Z | FDA UDI | Class I | Unknown |
| Universal Flex2®breathing Circuit | DF376R-60Z | FDA UDI | Class I | Unknown |
| Universal F® Flex2® | AF376-6127Z | FDA UDI | Class I | Active |
| 22mm X 22mm I.d. Adapter | 838-486-50F | FDA UDI | Class I | Active |
| Flex Connector | 101067 | FDA UDI | Class I | Active |
| Pediatric Ultra Flex®anesthesia Breathing Circuit | 2705Y-136 | FDA UDI | Class I | Unknown |
| Universal F® Flex2® | AF4110-6121Z | FDA UDI | Class I | Active |
| Pediatric Ultra Flex®anesthesia Breathing Circuit | 2907P-41022 | FDA UDI | Class I | Unknown |
| Universal F2®breathing Circuit & Pack Kit | F94474 | FDA UDI | Class I | Active |
| Universal F2®anesthesia Breathing Circuit | D060-61 | FDA UDI | Class I | Unknown |
| Adult Ultra Flex® | 8903B-61Z | FDA UDI | Class I | Active |
| Ventilator Circuit | 20740F-C | FDA UDI | Class I | Unknown |
| Pediatric Anesthesiabreathing Circuit | 2607Y-6127 | FDA UDI | Class I | Unknown |
| Universal Flex2®breathing Circuit | DF375-17621Z | FDA UDI | Class I | Active |
| Ventilator Circuit | 40750 | FDA UDI | Class I | Active |
| Jackson Rees | 3743-321WSZ | FDA UDI | Class I | Active |
| Adult Ultra Flex®anesthesia Breathing Circuit | 8753F-19021Z | FDA UDI | Class I | Active |
| Universal Flex2®breathing Circuit | DF475-61Z | FDA UDI | Class I | Active |
| Universal F2 Circuitanesthesia Breathing Circuit | D366-6021Z | FDA UDI | Class I | Unknown |
| Adult Ultra Flex®anesthesia Breathing Circuit | V5754F-6121Z | FDA UDI | Class I | Active |
| Universal Flex2®breathing Circuit | KNCF376-6121Z | FDA UDI | Class I | Active |
| Pediatric Ultra Flex® | 2700-61 | FDA UDI | Class I | Active |
| Adult Anesthesiabreathing Circuit | 8603F-13233Z | FDA UDI | Class I | Unknown |
| Universal Flex2®breathing Circuit | DF4115-618Z | FDA UDI | Class I | Active |
| Ped F2® Pediatricanesthesia Breathing Circuit | PD040-61 | FDA UDI | Class I | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (100)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Feb 17, 2015 | Z-1361-2015 | — | terminated | Product is mislabeled as Double Swivel Connector with Suction Port and is actually Double Swivel Connector without Suction port. If the incorrect component is not identified prior to clinical use, the incorrect connector would be replaced during the case without risk to the patient and could result in a short delay of the procedure. |
| Sep 3, 2013 | Z-2255-2013 | — | terminated | Report that size 5 KLTD airways were packaged in pouches indicating a size of 2.5 and shipped to your facility. The correct size of the KLTD airway is clearly marked on the actual airway product and the physical size difference between 2.5 and 5 is distinct and obvious. |
| Nov 2, 2012 | Z-0426-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Nov 2, 2012 | Z-0420-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Nov 2, 2012 | Z-0421-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Nov 2, 2012 | Z-0418-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Nov 2, 2012 | Z-0419-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Nov 2, 2012 | Z-0425-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Nov 2, 2012 | Z-0427-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Nov 2, 2012 | Z-0423-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Nov 2, 2012 | Z-0424-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Nov 2, 2012 | Z-0422-2013 | — | terminated | The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO |
| Aug 23, 2012 | Z-2272-2013 | — | terminated | King Systems received a customer complaint indicating that the customer had ordered a breathing circuit with a Latex breathing bag. The product they received contained a Latex breathing bag, but was labeled as non-latex. |
| Jan 24, 2011 | Z-1889-2011 | — | terminated | The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm. |
| Jan 24, 2011 | Z-1879-2011 | — | terminated | The firms contract manufacturer reported that the products were below the specification for hardness. This could contribute to a higher incidence of problems during the insertion and final positioning of the airway in the patient. In rare instances the softness of the tube could cause the tube to fold over. |
| Jan 24, 2011 | Z-1888-2011 | — | terminated | The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm. |
| Jan 24, 2011 | Z-1890-2011 | — | terminated | The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm. |
| Jan 24, 2011 | Z-1887-2011 | — | terminated | The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm. |
| Jan 24, 2011 | Z-1892-2011 | — | terminated | The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm. |
| Jan 24, 2011 | Z-1878-2011 | — | terminated | The firms contract manufacturer reported that the products were below the specification for hardness. This could contribute to a higher incidence of problems during the insertion and final positioning of the airway in the patient. In rare instances the softness of the tube could cause the tube to fold over. |
| Jan 24, 2011 | Z-1891-2011 | — | terminated | The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm. |
| Jan 14, 2011 | Z-1718-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1706-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1714-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1720-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1721-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1707-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1710-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1717-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1713-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1712-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1705-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1708-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1715-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1709-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1719-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1716-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Jan 14, 2011 | Z-1711-2011 | — | terminated | King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca |
| Dec 15, 2009 | Z-0978-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0986-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0975-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0980-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0976-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0982-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0984-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0985-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0983-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0974-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0977-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0981-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Dec 15, 2009 | Z-0979-2011 | — | terminated | King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat |
| Aug 1, 2008 | Z-0789-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0745-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0795-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0809-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0730-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0794-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0721-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0757-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0691-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0701-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0804-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0813-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0685-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0687-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0729-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0734-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0758-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0807-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0696-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0699-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0783-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0816-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0709-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0700-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0714-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0689-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0805-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0812-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0742-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0748-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0796-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0782-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0790-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0736-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0800-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0724-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0683-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0761-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0814-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0682-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0679-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0764-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0681-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0773-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0722-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0740-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0752-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0772-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |
| Aug 1, 2008 | Z-0785-2009 | — | terminated | The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels. |